BAttLe Against COVID-19 Using MesenchYmal Stromal Cells

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The investigational medicinal product consists of expanded allogeneic mesenchymal stromal cells derived from adipose tissue and administered intravenously. The objective of this project is to evaluate the safety and efficacy of the administration of expanded allogeneic adipose tissue adult mesenchymal stem cells, in patients infected with SARS-COV-2 with COVID-19 type complications.
Epistemonikos ID: e20a295a2eaa727e8e60b6a079c61d0ed888d28e
First added on: Apr 17, 2020